Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes - Wikidata - wikimedia - TriplyDB

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

http://www.wikidata.org/entity/Q24250287

about

Puerarin injection for unstable angina pectoris Heparin versus placebo for non-ST elevation acute coronary syndromes Heparin versus placebo for acute coronary syndromes Puerarin injection for unstable angina pectoris Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review.Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital.

P2860

Q24185802-E920D818-74FC-4781-A109-AE7E9E8771C0 Q24193744-8C90337A-5380-4283-9409-6DE9F9299973 Q24243000-18B11941-CB4A-4C45-9B9A-CBF9C47927D6 Q24244939-40A258BC-27FE-4BD1-9D3D-9880C4F4C854 Q34415964-D2782FF7-E56B-476F-BF2D-A2CA30B4CEFF Q34503038-4AD1493B-FD38-4123-A057-78A60A01FFB2

P2860

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

http://www.wikidata.org/entity/Q24250287

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@ast

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@en

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@en-gb

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@nl

type

label

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@ast

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@en

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@en-gb

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@nl

prefLabel

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@ast

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@en

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@en-gb

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@nl

P1433

Q24250287-3233DD82-E285-42F5-809B-6C1264227B9D

P1476

Q24250287-62A25591-1E9F-425A-86B9-BA9ED4644A30

P2093

Q24250287-9407C253-1A3D-49D3-BFA1-EE6334EC9D73

Q24250287-B34A496E-6811-4FBE-A29E-964D80FD44BB

Q24250287-DA397C1A-4F14-4774-8EB5-ADD4EB903063

P2860

Q24250287-04F70C6A-9BAD-4488-914A-4C5D3678FD3B

Q24250287-49CC89ED-3CE0-4015-BA5D-5993EDE2CA48

Q24250287-4B3BB2EE-555B-4A09-9FF4-8B7DA498BC53

Q24250287-7725B315-B102-45FF-833B-4277430D3933

Q24250287-93AE6805-49DA-4C7C-87F0-E44C7DF2C51E

Q24250287-9D6C1C31-5A3B-46CB-B0B0-7AA9654A501F

Q24250287-A7153741-7708-441C-9A0F-ED11602E3242

Q24250287-AB0C9F02-632B-4956-9560-65496EEABC3F

Q24250287-B4ECA1AF-9502-43C1-BE81-F6D257B2E9CD

Q24250287-B6EF81F9-BE2E-48E5-B33B-D8675DB048C4

P31

Q24250287-3001C672-DE8C-4C94-AB09-4D0EC544CC03

Q24250287-e8cdbe2c-fafc-43ce-9c2c-ee236d8b28bb

P356

Q24250287-CE0173F7-9793-42F0-9FC2-C0008EB1B8AA

P50

Q24250287-4443BC62-CADC-4534-858F-E3368B7BE5A7

P577

Q24250287-3FDBDBC2-6A96-423C-A156-57509376D321

P5875

Q24250287-4DE1ACA6-9283-4922-967C-BB93D4F2F89F

P698

Q24250287-D3A931A1-523F-4220-B1B3-F3F183594D05

P356

14651858.CD002132

P1433

Cochrane Database of Systematic Reviews

P1476

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes

@en

P2093

Brian H Rowe

http://www.w3.org/2001/XMLSchema#string

Kirk Magee

http://www.w3.org/2001/XMLSchema#string

William W Sevcik

http://www.w3.org/2001/XMLSchema#string

P2860

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Elucidation of the role of plaque instability and rupture in acute coronary events.

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis.

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.

Heparin is more effective than inogatran, a low-molecular weight thrombin inhibitor in suppressing ischemia and recurrent angina in unstable coronary disease. Thrombin Inhibition in Myocardial Ischemia (TRIM) Study Group.

P31

scholarly article

P356

10.1002/14651858.CD002132

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10944785

http://www.w3.org/2001/XMLSchema#string

P698

12535430

http://www.w3.org/2001/XMLSchema#string